Adoptive T-Cell Therapy for Solid Malignancies
- 1 July 2019
- journal article
- research article
- Published by Elsevier in Surgical Oncology Clinics of North America
- Vol. 28 (3) , 465-479
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockadeScience, 2017
- Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancerScience, 2015
- Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen ReceptorJournal of Clinical Oncology, 2015
- Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer ImmunotherapyClinical Cancer Research, 2011
- Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor LymphocytesScience, 2002
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.Journal of Experimental Medicine, 1985
- Elimination of syngeneic sarcomas in rats by a subset of T lymphocytes.Journal of Experimental Medicine, 1980
- Selective in Vitro Growth of T Lymphocytes from Normal Human Bone MarrowsScience, 1976
- TREATMENT OF PRIMARY FIBROSARCOMA IN THE RAT WITH IMMUNE LYMPHOCYTESThe Lancet, 1964